Suppr超能文献

Stauprimide 诱导人胚胎干细胞向确定的内胚层分化。

Stauprimide Priming of Human Embryonic Stem Cells toward Definitive Endoderm.

机构信息

Department of Biology, Kharazmi University, Tehran, Iran.

Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

出版信息

Cell J. 2014 Feb 3;16(1):63-72.

Abstract

OBJECTIVE

In vitro production of a definitive endoderm (DE) is an important issue in stem cell-related differentiation studies and it can assist with the production of more efficient endoderm derivatives for therapeutic applications. Despite tremendous progress in DE differentiation of human embryonic stem cells (hESCs), researchers have yet to discover universal, efficient and cost-effective protocols.

MATERIALS AND METHODS

In this experimental study, we have treated hESCs with 200 nM of Stauprimide (Spd) for one day followed by activin A (50 ng/ml; A50) for the next three days (Spd-A50). In the positive control group, hESCs were treated with Wnt3a (25 ng/ml) and activin A (100 ng/ml) for the first day followed by activin A for the next three days (100 ng/ml; W/A100-A100).

RESULTS

Gene expression analysis showed up regulation of DE-specific marker genes (SOX17, FOXA2 and CXCR4) comparable to that observed in the positive control group. Expression of the other lineage specific markers did not significantly change (p<0.05). We also obtained the same gene expression results using another hESC line. The use of higher concentrations of Spd (400 and 800 nM) in the Spd-A50 protocol caused an increase in the expression SOX17 as well as a dramatic increase in mortality rate of the hESCs. A lower concentration of activin A (25 ng/ml) was not able to up regulate the DE-specific marker genes. Then, A50 was replaced by inducers of definitive endoderm; IDE1/2 (IDE1 and IDE2), two previously reported small molecule (SM) inducers of DE, in our protocol (Spd-IDE1/2). This replacement resulted in the up regulation of visceral endoderm (VE) marker (SOX7) but not DE-specific markers. Therefore, while the Spd-A50 protocol led to DE production, we have shown that IDE1/2 could not fully replace activin A in DE induction of hESCs.

CONCLUSION

These findings can assist with the design of more efficient chemically-defined protocols for DE induction of hESCs and lead to a better understanding of the different signaling networks that are involved in DE differentiation of hESCs.

摘要

目的

体外生成确定性内胚层(DE)是干细胞相关分化研究中的一个重要问题,它可以帮助生成更有效的治疗应用内胚层衍生物。尽管人类胚胎干细胞(hESC)的 DE 分化取得了巨大进展,但研究人员尚未发现普遍、高效且具有成本效益的方案。

材料与方法

在这项实验研究中,我们用 200 nM 的 Stauprimide(Spd)处理 hESC 一天,然后用激活素 A(50ng/ml;A50)处理接下来的三天(Spd-A50)。在阳性对照组中,hESC 先用 Wnt3a(25ng/ml)和激活素 A(100ng/ml)处理一天,然后用激活素 A 处理接下来的三天(100ng/ml;W/A100-A100)。

结果

基因表达分析显示,DE 特异性标记基因(SOX17、FOXA2 和 CXCR4)的表达上调与阳性对照组观察到的相似。其他谱系特异性标记物的表达没有显著变化(p<0.05)。我们还使用另一种 hESC 系获得了相同的基因表达结果。Spd-A50 方案中 Spd 浓度增加到 400 和 800 nM 会导致 SOX17 表达增加,同时 hESC 的死亡率也会显著增加。激活素 A 的浓度较低(25ng/ml)不能上调 DE 特异性标记基因。然后,用 IDE1/2(IDE1 和 IDE2)取代 A50,IDE1/2 是先前报道的两种小分子(SM)诱导 DE 的诱导剂,用于我们的方案(Spd-IDE1/2)。这一替代导致内脏内胚层(VE)标记物(SOX7)的上调,但没有 DE 特异性标记物。因此,虽然 Spd-A50 方案导致 DE 生成,但我们表明 IDE1/2 不能完全替代激活素 A 诱导 hESC 的 DE。

结论

这些发现可以帮助设计更有效的化学定义方案,用于诱导 hESC 的 DE,从而更好地理解参与 hESC 的 DE 分化的不同信号网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207e/3933440/fa0af12759d0/Cell-J-16-63-g01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验